Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer.

Singh, Manu Smriti; Ramishetti, Srinivas; Landesman-Milo, Dalit; Goldsmith, Meir; Chatterjee, Sushmita; Palakuri, Ramesh; Peer, Dan

Singh, Manu Smriti; Ramishetti, Srinivas; Landesman-Milo, Dalit; Goldsmith, Meir; Chatterjee, Sushmita; Palakuri, Ramesh; Peer, Dan.

Afiliación

Singh MS; Laboratory of Precision NanoMedicine, Tel Aviv University, Tel Aviv, 69978, Israel.
Ramishetti S; School of Molecular Cell Biology & Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.
Landesman-Milo D; Department of Materials Sciences & Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, 69978, Israel.
Goldsmith M; Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 69978, Israel.
Chatterjee S; Cancer Biology Research Center, Tel Aviv University, Tel Aviv, 69978, Israel.
Palakuri R; Laboratory of Precision NanoMedicine, Tel Aviv University, Tel Aviv, 69978, Israel.
Peer D; School of Molecular Cell Biology & Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.

Small ; 17(19): e2100287, 2021 05.

Article en En | MEDLINE | ID: mdl-33825318

Asunto(s)

Nanopartículas; Neoplasias Ováricas; Animales; Femenino; Silenciador del Gen; Humanos; Lípidos; Ratones; ARN Interferente Pequeño

Palabras clave

gene delivery; lipid nanoparticle; ovarian cancer; small interfering RNA; targeting

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Small Asunto de la revista: ENGENHARIA BIOMEDICA Año: 2021 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google